Vima Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $100M

  • Investors
  • 5

Vima Therapeutics General Information

Description

Developer of oral therapeutics designed for the treatment of movement disorders. The company offers clinical-stage biotechnology research focused on targeting the underlying causes of dystonia through advanced pharmacological approaches, providing patients with improved motor control, enhanced treatment efficacy, and better tolerability while addressing the neurological mechanisms responsible for involuntary muscle contractions.

Contact Information

Website
www.vimatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Kendall Square, Building 200
  • Suite 2-402
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • One Kendall Square, Building 200
  • Suite 2-402
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vima Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 11-Mar-2026 $100M Completed Clinical Trials - Phase 1
To view Vima Therapeutics’s complete valuation and funding history, request access »

Vima Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Vima Therapeutics’s complete cap table history, request access »

Vima Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vima Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Access Biotechnology Corporate Venture Capital Minority
Atlas Venture Venture Capital Minority
Canaan Creative Holding Company Minority
Canaan Partners Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
To view Vima Therapeutics’s complete investors history, request access »

Vima Therapeutics FAQs

  • When was Vima Therapeutics founded?

    Vima Therapeutics was founded in 2023.

  • Where is Vima Therapeutics headquartered?

    Vima Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Vima Therapeutics?

    Vima Therapeutics has 20 total employees.

  • What industry is Vima Therapeutics in?

    Vima Therapeutics’s primary industry is Drug Discovery.

  • Is Vima Therapeutics a private or public company?

    Vima Therapeutics is a Private company.

  • What is the current valuation of Vima Therapeutics?

    The current valuation of Vima Therapeutics is .

  • What is Vima Therapeutics’s current revenue?

    The current revenue for Vima Therapeutics is .

  • How much funding has Vima Therapeutics raised over time?

    Vima Therapeutics has raised $100M.

  • Who are Vima Therapeutics’s investors?

    Access Biotechnology, Atlas Venture, Canaan Creative, Canaan Partners, and Frazier Healthcare Partners have invested in Vima Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process